PCG Digital: Soligenix Enters Q4 With Multiple Catalysts in Play
New York, New York--(Newsfile Corp. - October 13, 2022) - PCG Digital -- Late-stage biopharmaceutical company, Soligenix, Inc. (NASDAQ: SNGX) is anticipating significant catalysts in Q4 and a potentially
New York United States National Institutes Of Health Soligenix Public Health Solutions Digital Holdings Public Health Solutions
Source: finanznachrichten.de